Open AccessJournal Article
[Preparation of doxorubicin-loaded stealth liposomes modified with RGD mimetic and cellular association in vitro].
Reads0
Chats0
TLDR
The RGDm-modified SL could be as the targeted carriers to facilitate the delivery of the encapsulated anti-cancer drugs into tumor cells by receptor-mediated way.Abstract:
Aim To investigate the possibility of using stealth liposomes modified with arginine-glycine-aspartic acid (RGD) mimetic as the targeted carriers to achieve increased accumulation in tumor and enhanced intracellular delivery for the encapsulated anticancer drugs. Methods RGD mimetic (RGDm) as a ligand for integrins was synthesized and covalently conjugated to the active PEGylated phospholipids (DSPE-PEG-BTC) to form RGDm conjugate (DSPE-PEG-RGDm). Then RGDm-modified SL (RGDm-SL) containing DOX (RGDm-SL-DOX) and SL containing DOX (SL-DOX) were prepared by film dispersion followed by ammonium sulfate gradient method. The pH-sensitive probe, BCECF-AM, was used to study the binding of melanoma cells to DSPE-PEG-RGDm. Flow cytometry and confocal microscopy were performed to evaluate the cellular association or DOX uptake for RGDm-SL-DOX or SL-DOX in vitro. Results The melanoma cells A375 and B16 showed enhanced binding to the immobilized DSPE-PEG-RGDm. The cells treated with RGDm-SL-DOX showed remarkable increase in cellular association or DOX uptake compared with SL-DOX. Conclusion The RGDm-modified SL could be as the targeted carriers to facilitate the delivery of the encapsulated anti-cancer drugs into tumor cells by receptor-mediated way.read more
Citations
More filters
Journal ArticleDOI
Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
TL;DR: Investigating the in vitro cytotoxicity of free and encapsulated PTX against MDA-MB-435 cancer cell line versus two normal cells, Human Umbilical Vein Endothelial Cells (HUVEC) and MCF10A cells, showed both peptide ligands to facilitate the association of micelles with Mda- MB-435 cells.
Journal ArticleDOI
Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
Sangeeta K. Cheema,Andrea S. Gobin,Robyn Rhea,Gabriel Lopez-Berestein,Robert A. Newman,Anshu B. Mathur +5 more
TL;DR: It is demonstrated that silk fibroin coating enhanced emodin delivery in Her2/neu over-expressing breast cancer cells thereby increasing the overall efficacy of the drug.
Book ChapterDOI
Liposomes as Carriers of Anticancer Drugs
Sávia Caldeira de Araújo Lopes,Cristiane dos Santos Giuberti,TalitaGuieiro Ribeiro Rocha,Diego dos Santos Ferreira,Elaine AmaralLeite,Mônica Cristina de Oliveira +5 more
TL;DR: Liposomes can be used to improve current cancer treatment regimens due to their capacity to increase the solubility of poorly water-soluble antitumor drugs and to decrease the mononuclear phagocyte system’s uptake by using long-circulating liposomes.
Journal ArticleDOI
Novel Tetrapeptide, RGDF, Mediated Tumor Specific Liposomal Doxorubicin (DOX) Preparations
TL;DR: Improved tumor growth inhibition with L-RGDF-DOXs over doxorubicin hydrochloride solution, L- DOX and L-GGDFC12-DOx is shown, which is known to express α(v)β(3) integrin in tumor cells inoculated with sarcoma S(180).
Journal ArticleDOI
Preparation and biological evaluation of tumor-specific Ara-C liposomal preparations containing RGDV motif
TL;DR: A novel tetrapeptide was designed and attached to the N position of 1-β-D-arabinofuranosylcytosine at the valine end, as a homing device for the delivery of Ara-C to tumor cells, showing an enhanced antitumor activity in mice inoculated with sarcoma S(180).